(PharmaNewsWire.Com, August 05, 2020 ) Surface disinfectants are used to prevent microbial cross-contamination and transmission of microbial infections through surfaces in hospitals, pathology labs, and other patient-related areas. They are also used in research laboratories and pharmaceutical and biotechnology companies where human cells are handled and maintained for the purpose of research and development. These surface disinfectants are used to clean walls/floors, and other surfaces in hospitals and are also used in the disinfection of medical devices and instruments.
How the Market Growth looks like and Industry Segmentation?
The Global Surface Disinfectant Market is expected to reach USD 1,251.6 Million by 2024, at a CAGR of 8.4% during forecast period.
On the basis of type, the surface disinfectants market is segmented into liquids, wipes, and sprays. The liquids segment is expected to account for the largest market share in 2019. This can primarily be attributed to the wide usage of these disinfectants, especially in emerging and underdeveloped countries, due to their low cost.
By end user, the surface disinfectants market is segmented into hospital settings, diagnostic laboratories, pharmaceutical & biotechnology companies, and research laboratories. In 2019, hospital settings are expected to account for the largest share of the market. The large share of this segment can be attributed to factors, such as the high prevalence of infections in hospitals, the increase in hospital reimbursements for surgeries performed in hospitals, and growing patient volume in these healthcare settings.
Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient’s stay at hospitals and related facilities but are not observed at the time of admission. These infections include central line-associated bloodstream infections, surgical site infections, catheter-associated urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and Clostridium difficile infections.
The incidence of HAIs is mainly dependent on the patient’s immune status, infection control practices, and the prevalence of various infectious agents around the healthcare facility. Other factors include longer hospital stays, immunosuppression, older age, and stays in intensive care units. Around 20% of such infections occur in the ICUs. The major pathogens causing HAIs include C. difficile, Staphylococcus aureus, Klebsiella, and Escherichia coli. The transmission of pathogens can occur by direct contact with healthcare workers or contaminated environment. Pathogens tend to colonize in warm and moist areas such as the inguinal and perineal areas, axilla, and trunk.
Major Market Growth Drivers:
- Stringent Regulations for the Use of Surface Disinfectants - High Prevalence of Hais - Technological Improvements in Disinfectants - Growing Healthcare Industry in Emerging Economies
Based on region, the surface disinfectant market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America is projected to command the largest share of the surface disinfectants market. The large share of this market segment can be attributed majorly to the high prevalence of HAIs and the presence of stringent infection control regulations in the region.
The major players operating in this market are 3M Company (US), Procter & Gamble (US), Reckitt Benckiser Group plc. (UK), Clorox Company (US), and Ecolab (US).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
